SCHEMBL7110532

SCHEMBL7110532

CCCCC1(O)CCN(CCCCCn2c(=O)cc(Nc3ccc(C)c(CC)c3)[nH]c2=O)CC1.CCCCC1(O)CCN(Cc2ccccc2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7037823 0.94 — —
SCHEMBL3471013 0.88 — —
SCHEMBL3476316 0.80 — —
SCHEMBL11997019 0.78 — —
SCHEMBL3470220 0.78 — —
Hydrochloric Acid SCHEMBL3471759 0.78 — —
Hydrochloric Acid SCHEMBL3470957 0.77 — —
SCHEMBL3470402 0.76 — —
SCHEMBL7039037 0.76 — —
SCHEMBL3470407 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003011297-A1 N3-SUBSTITUTED 6-ANILINOPYRIMIDINES AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS UNIVERSITY OF MASSACHUSETTS (US) 2003-02-13 — — WO disclosed
Send feedback